Avingtrans (AVG) AI Stock Analysis

• Market Cap: £125.74M
• Dividend Yield: 1.24%
• Average Volume (3M): 18.16K
• Price to Earnings (P/E): 29.1
• Beta (1Y): 0.57
• Revenue Growth: 14.30%
• EPS Growth: -25.58%
• Country: UK
• Employees: 941
• Sector: Industrials
• Sector Strength: 89
• Industry: Industrial - Machinery
• EPS (TTM): 0.13
• Shares Outstanding: 33,089,924
• 10 Day Avg. Volume: 19,390
• 30 Day Avg. Volume: 18,163
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Avingtrans receives a solid overall score due to strong revenue growth and operational efficiency, though profitability and cash flow challenges pose risks. Technical indicators show positive momentum, but valuation concerns suggest caution. Recent corporate events underscore strategic growth, further supporting the company's future prospects.

Avingtrans Business Overview & Revenue Model

Company Description

Avingtrans plc manufactures and sells engineered components, systems, and services to the energy, medical, and infrastructure industries worldwide. It operates in three segments: Energy-EPM, Energy-PSRE, and Medical-MII. The company designs, manufactures, integrates, and services electric motors and pumps, steam turbines, gas compressors, pressure vessels, blast doors, containers, and skidded systems. It also designs and manufactures equipment for the medical, science and research communities, including products for medical diagnostic equipment; high performance pressure, vacuum vessels, and composite materials for research organizations; and superconducting magnets and helium-free cryogenic systems for use in magnetic resonance imaging and nuclear magnetic resonance. The company was incorporated in 1985 and is based in Chatteris, the United Kingdom.

How the Company Makes Money

Avingtrans makes money through the sale of its engineered components and systems across its three main divisions. In the Energy sector, it designs and manufactures equipment for the oil and gas, nuclear, and renewable energy markets. For the Medical division, the company produces components and systems for medical and scientific equipment, focusing on high-reliability and precision engineering. The Industrial division provides engineered solutions for various industrial applications. Revenue is generated through a combination of direct sales, long-term supply contracts, and strategic partnerships with key industry players, allowing Avingtrans to leverage its expertise and broaden its market reach.

Avingtrans Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
136.62M	116.44M	99.08M	98.52M	91.96M
	Gross Profit
44.04M	36.86M	32.59M	28.38M	22.21M
	EBIT
5.64M	8.24M	6.89M	7.18M	1.19M
	EBITDA
12.65M	13.20M	12.02M	11.03M	6.95M
	Net Income Common Stockholders
3.66M	5.19M	6.48M	3.99M	1.39M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
12.12M	17.72M	24.29M	30.08M	5.09M
	Total Assets
186.34M	155.41M	154.69M	142.61M	131.23M
	Total Debt
23.96M	8.58M	10.96M	9.80M	21.43M
	Net Debt
11.84M	-9.14M	-13.33M	-20.27M	16.35M
	Total Liabilities
73.33M	46.96M	48.88M	43.65M	61.33M
	Stockholders Equity
110.44M	106.04M	103.82M	97.30M	69.91M
Cash Flow		Free Cash Flow
-11.06M	985.00K	-1.10M	4.03M	-4.76M
	Operating Cash Flow
1.33M	9.68M	3.88M	6.45M	-13.00K
	Investing Cash Flow
-13.58M	-12.63M	-9.52M	24.56M	-4.02M
	Financing Cash Flow
6.78M	-3.40M	-371.00K	-5.85M	713.00K

Avingtrans Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 380.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:AVG, the sentiment is Positive. The current price of 380 is above the 20-day moving average (MA) of 354.20, above the 50-day MA of 346.06, and above the 200-day MA of 377.66, indicating a bullish trend. The MACD of 10.12 indicates Negative momentum. The RSI at 73.81 is Negative, neither overbought nor oversold. The STOCH value of 78.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:AVG.

Avingtrans Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GDWN	80 Outperform	£506.15M	25.95	16.39%	1.89%	3.13%	24.54%
RNO	75 Outperform	£120.27M	7.44	27.26%	0.94%	-6.48%	―
CGS	71 Outperform	£110.17M	9.13	9.51%	7.26%	-10.79%	-21.64%
AVG	70 Outperform	£125.74M	29.10	3.87%	1.24%	14.30%	-25.58%
MGAM	67 Neutral	£589.38M	11.91	14.06%	5.62%	-1.26%	6.56%
Sector *	64 Neutral	$4.40B	12.09	5.26%	250.03%	4.08%	-11.05%
MPAC	59 Neutral	£116.53M	40.83	1.63%	―	7.18%	-28.05%

Avingtrans Corporate Events

Avingtrans Reports Strong Interim Results with Significant Revenue Growth

Avingtrans PLC reported a strong financial performance for the six months ending November 30, 2024, with a 21.2% increase in group revenue to £79.0m and an 18.7% rise in adjusted EBITDA to £8.7m. The Advanced Engineering Systems division drove this growth, benefiting from global energy demand and infrastructure expansion. The Medical and Industrial Imaging division also showed progress, with initial sales of Adaptix products and expansion plans for Magnetica. The company remains optimistic about meeting its full-year targets, supported by a robust order book and strategic investments in key divisions.